zanamivir has been researched along with Disease, Pulmonary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gillissen, A; Höffken, G | 1 |
| Bailey, KW; Barnard, DL; Huffman, JH; Kim, CU; Morrison, A; Sidwell, RW; Syndergaard, T; Wong, MH | 1 |
1 review(s) available for zanamivir and Disease, Pulmonary
| Article | Year |
|---|---|
Efficacy and safety of zanamivir in patients with influenza--impact of age, severity of infections and specific risk factors.
Topics: Administration, Oral; Age Factors; Antiviral Agents; Bacterial Infections; Chronic Disease; Double-Blind Method; Guanidines; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Lung Diseases; Pyrans; Risk Factors; Sialic Acids; Time Factors; Treatment Outcome; Zanamivir | 2002 |
1 other study(ies) available for zanamivir and Disease, Pulmonary
| Article | Year |
|---|---|
Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor.
Topics: Acetamides; Administration, Intranasal; Administration, Oral; Amines; Animals; Antiviral Agents; Cell Line; Disease Models, Animal; Dogs; Enzyme Inhibitors; Female; Guanidines; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Lung Diseases; Mice; Mice, Inbred BALB C; Molecular Structure; Neuraminidase; Oseltamivir; Pyrans; Ribavirin; Sialic Acids; Zanamivir | 1998 |